Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

Clinical trial NCT05636787 · RECRUITING

Trial details

NCT number: NCT05636787
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2023-06-06
Primary completion: 2028-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.